Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer.
Sang W, Zhou Y, Chen H, Yu C, Dai L, Liu Z, Chen L, Fang Y, Ma P, Wu X, Kong H, Liao W, Jiang H, Qian J, Wang D, Liu YH.
Sang W, et al. Among authors: fang y.
Cancer Discov. 2024 Feb 8;14(2):326-347. doi: 10.1158/2159-8290.CD-23-0584.
Cancer Discov. 2024.
PMID: 37824278